Literature DB >> 22593438

Effect of miR-34b overexpression on the radiosensitivity of non-small cell lung cancer cell lines.

Joana Balça-Silva1, Sílvia Sousa Neves, Ana Cristina Gonçalves, Ana Margarida Abrantes, João Casalta-Lopes, Maria Filomena Botelho, Ana Bela Sarmento-Ribeiro, Henriqueta Coimbra Silva.   

Abstract

BACKGROUND: The miR-34 family, under-expressed in-non small cell lung cancers (NSCLCs), are effectors of p53 activation upon irradiation of cells. We evaluated whether the miR-34b overexpression modulates the NSCLCs response to radiation.
MATERIALS AND METHODS: NSCLC cell lines A549 with V-KI-RAS2 Kirsten Rat Sarcoma viral oncogene (KRAS) codon 12 mutation and with wild type p53, and H1299, not expressing p53, were irradiated after transfection with pre-miR-34b. Cell survival was assessed by clonogenic survival assays. The apoptosis and the cell cycle were evaluated by flow cytometry.
RESULTS: In the A549 cell line, overexpression of miR-34b significantly reduced cell survival at lower than 4 Gy radiation doses. There was a significant reduction in B-cell CLL/lymphoma 2 (BCL2) expression but no significant differences were observed in the apoptotic cell population or the cycle profile. No significant effect was recorded in the H1299 irradiated cells.
CONCLUSION: In the p53 wild type, KRAS mutated NSCLC cells, the overexpression of miR-34b increases radiosensitivity at low doses of radiation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22593438

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  30 in total

1.  The prognostic value of miR-34a expression in completely resected gastric cancer: tumor recurrence and overall survival.

Authors:  Huaping Zhang; Shaojun Li; Junqi Yang; Shuai Liu; Xiangqian Gong; Xiaofeng Yu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  MicroRNA: a connecting road between apoptosis and cholesterol metabolism.

Authors:  Yogita K Adlakha; Neeru Saini
Journal:  Tumour Biol       Date:  2016-04-22

3.  microRNA-664 enhances proliferation, migration and invasion of lung cancer cells.

Authors:  Xinhai Zhu; Sheng Ju; Feng Yuan; Guoping Chen; Yue Shu; Chuanchuan Li; Yanhui Xu; Jing Luo; Lilong Xia
Journal:  Exp Ther Med       Date:  2017-05-05       Impact factor: 2.447

4.  Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression.

Authors:  Yan Zhou; Rui-hua Zhao; Kuo-fu Tseng; Kun-peng Li; Zhi-gang Lu; Yuan Liu; Kun Han; Zhi-hua Gan; Shu-chen Lin; Hai-yan Hu; Da-liu Min
Journal:  Acta Pharmacol Sin       Date:  2016-02-29       Impact factor: 6.150

Review 5.  microRNA expression and biogenesis in cellular response to ionizing radiation.

Authors:  Aihong Mao; Yang Liu; Hong Zhang; Cuixia Di; Chao Sun
Journal:  DNA Cell Biol       Date:  2014-06-06       Impact factor: 3.311

Review 6.  MicroRNAs in lung cancer.

Authors:  Pooja Joshi; Justin Middleton; Young-Jun Jeon; Michela Garofalo
Journal:  World J Methodol       Date:  2014-06-26

Review 7.  MicroRNA as tools and therapeutics in lung cancer.

Authors:  Jennifer F Barger; S Patrick Nana-Sinkam
Journal:  Respir Med       Date:  2015-02-19       Impact factor: 3.415

Review 8.  MicroRNAs in the ionizing radiation response and in radiotherapy.

Authors:  Chanatip Metheetrairut; Frank J Slack
Journal:  Curr Opin Genet Dev       Date:  2013-02-28       Impact factor: 5.578

9.  Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells.

Authors:  Guiping Yu; Ning Zhong; Guoqiang Chen; Bin Huang; Song Wu
Journal:  Tumour Biol       Date:  2014-07-21

Review 10.  The roles of microRNAs and protein components of the microRNA pathway in lung development and diseases.

Authors:  Leah Cushing; Zhihua Jiang; Pingping Kuang; Jining Lü
Journal:  Am J Respir Cell Mol Biol       Date:  2015-04       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.